FDA Panel Says Benefits of J&J (JNJ) Birth Control Patch Outweigh Risks -Bloomberg
Go back to FDA Panel Says Benefits of J&J (JNJ) Birth Control Patch Outweigh Risks -Bloomberg| Johnson & Johnson (NYSE: JNJ) | Delayed: 268.04 +2.27 (0.85%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $265.77 | 52 Week High | $126.07 | |||
| Open | $265.78 | 52 Week Low | $94.28 | |||
| Day High | $268.38 | P/E | 55.73 | |||
| Day Low | $264.27 | EPS | $4.81 | |||
| Volume | 5,766,188 | |||||
